Association of antiviral therapy with reduced disease progression in chronic Hepatitis B patients: Results from a nation-wide cohort study

RESEARCH ARTICLE

Hippokratia 2016, 20(3):214-221

Vourli G, Papatheodoridis G, Raptopoulou M, Dalekos GN, Hounta A, Nikolopoulou G, Zouboulis-Vafeiadis I, Manesis E, Kitis G, Gogos C, Ketikoglou I, Hatzis G, Vasilialdis T, Karatapanis S, Mimidis K, Drakoulis C, Touloumi G, The HEPNET-Greece study
Department of Hygiene, Epidemiology and Medical Statistics, Athens University Medical School, Athens, Department of Gastroenterology, Athens University Medical School, “Laiko” General Hospital of Athens, Athens, 4th Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Department of Medicine & Research Laboratory of Internal Medicine, School of Medicine, University of Thessaly, Larissa, 4th Department of Internal Medicine, General University Hospital “Attikon”, Athens, Viral Hepatitis Committee, KEELPNO, Athens, First Department of Propaedeutic Medicine, Athens University Medical School “Laiko” General Hospital of Athens, Athens, Division of Internal Medicine, Athens University Medical School, Athens, Gastroenterology Clinic, General Hospital “G. Papanikolaou”, Thessaloniki, Department of Infectious Diseases, Patras University Hospital, Patras, Department of Internal Medicine, “Hippocration” General Hospital, Athens, Department of Pathophysiology, University of Athens, Athens, 3rd Department of Internal Medicine, Aristotle University of Thessaloniki, “Papageorgiou” Hospital, Thessaloniki, Department of Internal Medicine, General Hospital of Rhodes, Rhodes, Department of Medicine, Democritus University of Thrace, Alexandroupolis, 2nd Department of Internal Medicine, General Hospital of Nikaia, Athens, Greece